首页 > 最新文献

HERALD of North-Western State Medical University named after I.I. Mechnikov最新文献

英文 中文
Periostin as a marker of eosinophilic inflammation in patients with asthma and chronic obstructive pulmonary disease 作为哮喘和慢性阻塞性肺病患者嗜酸性粒细胞炎症标志物的包膜组织蛋白
Pub Date : 2024-07-03 DOI: 10.17816/mechnikov625938
V. Kuznetsov, Y. Kozlova, E. V. Frolova, A. Uchevatkina, L. V. Filippova, O. Aak, N. V. Vasilieva
BACKGROUND: Asthma and chronic obstructive pulmonary disease are common chronic respiratory diseases. Given their heterogeneity, the study of periostin is a relevant area for establishing the endotypes of airway inflammation and determining further therapy tactics. AIM: To evaluate periostin levels and determine its significance as a marker of eosinophilic inflammation in patients with asthma and chronic obstructive pulmonary disease. MATERIALS AND METHODS: The study included 59 patients with asthma and 33 patients with chronic obstructive pulmonary disease. The control group consisted of 37 apparently healthy people, comparable in age and sex, without allergic and bronchial obstructive diseases in anamnesis. The anamnesis data, the number of peripheral blood eosinophils and induced sputum, indices of external respiratory function were evaluated. Levels of specific immunoglobulin E to allergens, periostin level were determined in blood serum by immunoenzyme method. The obtained data were processed using STATISTICA 13 and SPSS Statistic 27 software systems. RESULTS: The maximum serum periostin concentration 22.5 (17–38) ng/ml was recorded in the patients with asthma, which was significantly higher than in the chronic obstructive pulmonary disease group [16 (12–21) ng/ml; p = 0.006] and control group [20.1 (14.6–24.8) ng/ml; p = 0.044]. The level of periostin in induced sputum in the patients with asthma was significantly higher than in the chronic obstructive pulmonary disease group — 0.05 (0.03–0.6) ng/ml vs 0.03 (0.02–0.04) ng/ml (p = 0.008). The study revealed the correlation between serum periostin level and eosinophil level (r = 0.406; p 0.05) and with forced expiratory volume in the first second after bronchodilator test (r = 0.366; p 0.05) as well as with forced expiratory volume in the first second divided by forced vital capacity after bronchodilator test (r = 0.572; p 0.05). CONCLUSIONS: Periostin is a promising marker of eosinophilic inflammation in patients with asthma, which can be considered as an indicator of fixed bronchial obstruction and a molecule linking T2-inflammation and airway remodelling. In a group of chronic obstructive pulmonary disease patients, the use of periostin for diagnostic and prognostic purposes requires further investigation and larger studies.
背景:哮喘和慢性阻塞性肺病是常见的慢性呼吸道疾病。鉴于这两种疾病的异质性,研究表皮生长因子是确定气道炎症内型和确定进一步治疗策略的相关领域。目的:评估哮喘和慢性阻塞性肺疾病患者的骨膜组织蛋白水平,并确定其作为嗜酸性粒细胞炎症标志物的意义。材料与方法:研究对象包括 59 名哮喘患者和 33 名慢性阻塞性肺病患者。对照组包括 37 名表面健康的人,年龄和性别相当,无过敏性疾病和支气管阻塞性疾病。对病史数据、外周血嗜酸性粒细胞和诱导痰的数量、外部呼吸功能指数进行了评估。通过免疫酶法测定了血清中过敏原特异性免疫球蛋白 E 的水平和包膜蛋白的水平。所得数据使用 STATISTICA 13 和 SPSS Statistic 27 软件系统进行处理。结果:哮喘患者血清中骨膜素的最高浓度为 22.5(17-38)纳克/毫升,明显高于慢性阻塞性肺病组[16(12-21)纳克/毫升;P = 0.006]和对照组[20.1(14.6-24.8)纳克/毫升;P = 0.044]。哮喘患者诱导痰中的表皮生长因子水平明显高于慢性阻塞性肺病组--0.05 (0.03-0.6) ng/ml vs 0.03 (0.02-0.04) ng/ml (p = 0.008)。研究显示,血清包膜生长因子水平与嗜酸性粒细胞水平(r = 0.406;P 0.05)、支气管扩张剂测试后第一秒用力呼气量(r = 0.366;P 0.05)以及支气管扩张剂测试后第一秒用力呼气量除以用力肺活量(r = 0.572;P 0.05)之间存在相关性。结论:表皮生长因子是哮喘患者嗜酸性粒细胞炎症的一个有前途的标记物,可被视为支气管固定阻塞的一个指标,也是连接 T2-炎症和气道重塑的一个分子。在一组慢性阻塞性肺病患者中,使用包膜生长因子进行诊断和预后需要进一步的调查和更大规模的研究。
{"title":"Periostin as a marker of eosinophilic inflammation in patients with asthma and chronic obstructive pulmonary disease","authors":"V. Kuznetsov, Y. Kozlova, E. V. Frolova, A. Uchevatkina, L. V. Filippova, O. Aak, N. V. Vasilieva","doi":"10.17816/mechnikov625938","DOIUrl":"https://doi.org/10.17816/mechnikov625938","url":null,"abstract":"BACKGROUND: Asthma and chronic obstructive pulmonary disease are common chronic respiratory diseases. Given their heterogeneity, the study of periostin is a relevant area for establishing the endotypes of airway inflammation and determining further therapy tactics. \u0000AIM: To evaluate periostin levels and determine its significance as a marker of eosinophilic inflammation in patients with asthma and chronic obstructive pulmonary disease. \u0000MATERIALS AND METHODS: The study included 59 patients with asthma and 33 patients with chronic obstructive pulmonary disease. The control group consisted of 37 apparently healthy people, comparable in age and sex, without allergic and bronchial obstructive diseases in anamnesis. The anamnesis data, the number of peripheral blood eosinophils and induced sputum, indices of external respiratory function were evaluated. Levels of specific immunoglobulin E to allergens, periostin level were determined in blood serum by immunoenzyme method. The obtained data were processed using STATISTICA 13 and SPSS Statistic 27 software systems. \u0000RESULTS: The maximum serum periostin concentration 22.5 (17–38) ng/ml was recorded in the patients with asthma, which was significantly higher than in the chronic obstructive pulmonary disease group [16 (12–21) ng/ml; p = 0.006] and control group [20.1 (14.6–24.8) ng/ml; p = 0.044]. The level of periostin in induced sputum in the patients with asthma was significantly higher than in the chronic obstructive pulmonary disease group — 0.05 (0.03–0.6) ng/ml vs 0.03 (0.02–0.04) ng/ml (p = 0.008). The study revealed the correlation between serum periostin level and eosinophil level (r = 0.406; p 0.05) and with forced expiratory volume in the first second after bronchodilator test (r = 0.366; p 0.05) as well as with forced expiratory volume in the first second divided by forced vital capacity after bronchodilator test (r = 0.572; p 0.05). \u0000CONCLUSIONS: Periostin is a promising marker of eosinophilic inflammation in patients with asthma, which can be considered as an indicator of fixed bronchial obstruction and a molecule linking T2-inflammation and airway remodelling. In a group of chronic obstructive pulmonary disease patients, the use of periostin for diagnostic and prognostic purposes requires further investigation and larger studies.","PeriodicalId":507931,"journal":{"name":"HERALD of North-Western State Medical University named after I.I. Mechnikov","volume":" 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141680578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retroperitoneal synovial sarcoma 腹膜后滑膜肉瘤
Pub Date : 2024-01-13 DOI: 10.17816/mechnikov624440
A. A. Lisitsyn, V. Zemlyanoy, I. Kotkas, I. Bekhtereva
Synovial sarcoma of the retroperitoneum is a rare and aggressive tumor. In some cases, differential diagnosis between retroperitoneal sarcoma and adrenocortical cancer is difficult due to the similar clinical and intrascopic manifestations of these neoplasms. The final diagnosis is established based on the results of histological, immunohistochemical and genetic studies. The most important step in the treatment of synovial sarcoma is complete removal of the tumor. However, despite the radical nature of the intervention, the incidence of local relapse and metastasis remains high. AIM: to conduct a retrospective analysis of the parameters of operated patients with synovial sarcoma of the retroperitoneum. This study is aimed at studying the results of examination and surgical treatment of patients with synovial sarcoma of the retroperitoneal space who were hospitalized in the E.E. Eichwald Clinic surgical department of the North-Western State Medical University named after. I.I. Mechnikov. The patients were assessed for hormonal status using an immunoassay to determine the levels of adrenocorticotropic hormone, cortisol, aldosterone, renin, normetanephrine and metanephrine in the blood, and a dexamethasone suppression test has been performed at a dose of 1 mg. High-performance liquid chromatography has determined 6 glucocorticoids in the blood serum: cortisol, cortisone, corticosterone, 11-deoxycorticosterone, 11-dehydrocorticosterone, 11-deoxycortisol. The urine steroid profile was studied in all the patients using gas chromatography-mass spectrometry. All the patients underwent computed tomography of the abdominal organs and retroperitoneal space with contrast, morphological and immunohistochemical examination of the removed material. The material was fixed in 10% neutral buffered formalin. The pieces were then subjected to standard wiring followed by embedding in paraffin. Sections 2–3 microns thick were prepared from the resulting blocks and stained with hematoxylin and eosin. Immunohistochemical studies were performed on paraffin sections. A panel of monoclonal antibodies was used: protein S-100 (poly), pancytokeratin (AE1/AE3), EMA, cytokeratin-8, -18, chromogranin A, synaptophysin, α-inhibin, SOX-10, CD99, TLE-1, bcl- 2, GATA-3. Postoperative outcomes and follow-up were assessed according to the information in the medical records and data obtained from a telephone conversation with each patient. Statistical processing of the results has not been out due to rare cases of the disease.
腹膜后滑膜肉瘤是一种罕见的侵袭性肿瘤。在某些病例中,由于腹膜后肉瘤和肾上腺皮质癌的临床和内在表现相似,因此很难鉴别诊断。最终诊断要根据组织学、免疫组化和遗传学研究的结果来确定。治疗滑膜肉瘤最重要的一步是彻底切除肿瘤。然而,尽管采取了根治性干预措施,局部复发和转移的发生率仍然很高。目的:对腹膜后滑膜肉瘤手术患者的参数进行回顾性分析。本研究旨在研究在西北国立医科大学 E.E. Eichwald 诊所外科住院的腹膜后间隙滑膜肉瘤患者的检查和手术治疗结果。梅奇尼科夫(I.I. Mechnikov)命名的西北国立医科大学 E.E. Eichwald 诊所外科住院治疗的患者。使用免疫测定法测定血液中促肾上腺皮质激素、皮质醇、醛固酮、肾素、去甲肾上腺素和甲肾上腺素的水平,评估患者的激素状况,并以 1 毫克的剂量进行地塞米松抑制试验。高效液相色谱法测定了血清中的 6 种糖皮质激素:皮质醇、可的松、皮质酮、11-脱氧皮质酮、11-脱氢皮质酮、11-脱氧皮质醇。使用气相色谱-质谱法对所有患者的尿液类固醇概况进行了研究。所有患者都接受了腹部器官和腹膜后间隙的计算机断层扫描,并对取出的材料进行了造影、形态学和免疫组化检查。材料在 10%的中性缓冲福尔马林中固定。然后对切片进行标准布线,再嵌入石蜡。用石蜡块制备 2-3 微米厚的切片,并用苏木精和伊红染色。对石蜡切片进行免疫组化研究。使用了一组单克隆抗体:S-100蛋白(多聚)、泛角蛋白(AE1/AE3)、EMA、细胞角蛋白-8、-18、嗜铬粒蛋白A、突触素、α-抑制素、SOX-10、CD99、TLE-1、bcl- 2、GATA-3。术后效果和随访情况根据病历信息和与每位患者的电话交谈获得的数据进行评估。由于病例极少,因此未对结果进行统计处理。
{"title":"Retroperitoneal synovial sarcoma","authors":"A. A. Lisitsyn, V. Zemlyanoy, I. Kotkas, I. Bekhtereva","doi":"10.17816/mechnikov624440","DOIUrl":"https://doi.org/10.17816/mechnikov624440","url":null,"abstract":"Synovial sarcoma of the retroperitoneum is a rare and aggressive tumor. In some cases, differential diagnosis between retroperitoneal sarcoma and adrenocortical cancer is difficult due to the similar clinical and intrascopic manifestations of these neoplasms. The final diagnosis is established based on the results of histological, immunohistochemical and genetic studies. The most important step in the treatment of synovial sarcoma is complete removal of the tumor. However, despite the radical nature of the intervention, the incidence of local relapse and metastasis remains high. \u0000AIM: to conduct a retrospective analysis of the parameters of operated patients with synovial sarcoma of the retroperitoneum. \u0000This study is aimed at studying the results of examination and surgical treatment of patients with synovial sarcoma of the retroperitoneal space who were hospitalized in the E.E. Eichwald Clinic surgical department of the North-Western State Medical University named after. I.I. Mechnikov. \u0000The patients were assessed for hormonal status using an immunoassay to determine the levels of adrenocorticotropic hormone, cortisol, aldosterone, renin, normetanephrine and metanephrine in the blood, and a dexamethasone suppression test has been performed at a dose of 1 mg. High-performance liquid chromatography has determined 6 glucocorticoids in the blood serum: cortisol, cortisone, corticosterone, 11-deoxycorticosterone, 11-dehydrocorticosterone, 11-deoxycortisol. The urine steroid profile was studied in all the patients using gas chromatography-mass spectrometry. All the patients underwent computed tomography of the abdominal organs and retroperitoneal space with contrast, morphological and immunohistochemical examination of the removed material. The material was fixed in 10% neutral buffered formalin. The pieces were then subjected to standard wiring followed by embedding in paraffin. Sections 2–3 microns thick were prepared from the resulting blocks and stained with hematoxylin and eosin. Immunohistochemical studies were performed on paraffin sections. A panel of monoclonal antibodies was used: protein S-100 (poly), pancytokeratin (AE1/AE3), EMA, cytokeratin-8, -18, chromogranin A, synaptophysin, α-inhibin, SOX-10, CD99, TLE-1, bcl- 2, GATA-3. Postoperative outcomes and follow-up were assessed according to the information in the medical records and data obtained from a telephone conversation with each patient. Statistical processing of the results has not been out due to rare cases of the disease.","PeriodicalId":507931,"journal":{"name":"HERALD of North-Western State Medical University named after I.I. Mechnikov","volume":"13 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140509380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
HERALD of North-Western State Medical University named after I.I. Mechnikov
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1